Related Experiment Video
Updated: May 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Optimization of Impella 5.0 implantation using mini-sternotomy approach in postmyocardial infarction cardiogenic
Pierre Oses1, Frederic Casassus, Lionel Leroux
1CHU de Bordeaux, service de chirurgie cardiaque, Pessac, Bordeaux, France.
Abstract:
The Impella Recover LP 5.0® (Abiomed, Inc. Danvers, MA, USA) is an aortic transvalvular microaxial pump designed to unload the left ventricle and to ensure a systemic flow in severe left ventricular dysfunction. Surgical implantation using femoral or right subclavian approach may be difficult in certain circumstances, such as encountered in peripheral vascular disease, patients with small vessels or during substantial use of vasoactive drugs responsible for vasospasm. We propose a simple and effective technique for implantation of the Impella 5.0 LVAD by means of a mini-sternotomy in patients with postinfarction refractory cardiogenic shock.
